Bellicum Pharmaceuticals Inc. | Key People and Executives
Richard A. Fair
President, Chief Executive & Financial Officer
James Farrell Brown
Chairman
Edmund P. Harrigan
Independent Director
James M. Daly
Independent Director
Stephen R. Davis
Independent Director
Jon P. Stonehouse
Independent Director
Frank B. McGuyer
Independent Director
Reid M. Huber
Independent Director
Richard A. Fair
President, Chief Executive & Financial Officer
David M. Spencer
Chief Technology Officer
William Grossman
Chief Medical Officer
Gregory S. Naeve
Chief Business Officer
Joseph Howard Senesac
Vice President-Viral Vector Development
Alan K. Smith
Executive Vice President-Technical Operations
Scott N. Cullison
VP-Commercial Planning & Program Management
Rosemary Williams
Chief Accounting Officer, VP-Finance & Controller
Anne Frese
Vice President-Human Resources
Shane M. Ward
Secretary & General Counsel
Martha French
Vice President-Regulatory Affairs
James Farrell Brown
Chairman
Edmund P. Harrigan
Independent Director
James M. Daly
Independent Director
Stephen R. Davis
Independent Director
Jon P. Stonehouse
Independent Director
Frank B. McGuyer
Independent Director
Reid M. Huber
Independent Director
| Address |
Life Science Plaza
Houston Texas 77030
United States
|
|
Employees
|
- |
| Website |
http://www.bellicum.com |
| Updated |
07/08/2019 |
| Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. It uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. The company was founded by Kevin M. |
